EXPERIENCE

Stephen's recent representative transactions include advising:

Life Sciences and Digital Health

• Affini-T Therapeutics on its US$175 million equity financing
• Overjet on its US$53 million Series C financing and numerous other debt and equity financings
• PathAI on its US$165 million Series C financing
• BlueWhale Bio on its US$18 million seed financing 
• Rapid Micro Biosystems on its IPO and multiple private financings and strategic transactions
• Neurogene on its US$115 million equity financing and numerous other private financings
• Kiniksa Pharmaceuticals on its US$150 million IPO and multiple private financings and strategic transactions
• CloudHealth on its sale to VMware, Inc.
• Owkin on its US$180 million investment from Sanofi, US$80 million investment from BMS, and other equity financings

Technology

• MadHive on its US$300 million investment from Goldman Sachs Asset Management
• Merlin Labs on its US$105 million Series B financing
• OfferFit on its numerous debt and equity financings 
• Robin on its US$30 million Series C financing
• Riversand Technologies on its sale to Syndigo
• Evolv Technology on its US$1.7 billion SPAC merger with NewHold Investment Corporation
• Actifio on its sale to Google and numerous debt and equity financings
• Charles River Systems on its US$2.6 billion sale to State Street Corporation
• Amphenol on its US$400 million acquisition of SSI Controls Technologies
• Veracode on its US$614 million sale to CA Technologies
• Care.com in its IPO and numerous acquisitions
• Zipcar on its IPO and sale to Avis Budget Group